SBT-11-5301

N/A

Report date: 2022/06/09 16:14:41

Base Information

Drug NameSBT-11-5301
Drug Alias NameSBT115301
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionT lymphocytes modulatorsT-cell surface antigen CD2 binders
TargetsT-cell surface antigen CD2
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSonoma Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSonoma Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A